![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | A61P 39/00 | (2006.01) |
A61P 35/00 | (2006.01) | ||
A61K 47/68 | (2017.01) |
(11) | Patento numeris | 2906298 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13785831.2 |
Europos patento paraiškos padavimo data | 2013-10-11 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-03 |
(46) | Apibrėžties vertimo paskelbimo data | 2018-12-27 |
(86) | Numeris | PCT/EP2013/071346 |
Data | 2013-10-11 |
(87) | Numeris | WO 2014/057117 |
Data | 2014-04-17 |
(30) | Numeris | Data | Šalis |
201261712924 P | 2012-10-12 | US | |
201261712928 P | 2012-10-12 | US | |
201361784421 P | 2013-03-14 | US | |
201361784362 P | 2013-03-14 | US | |
201361784383 P | 2013-03-14 | US |
(72) |
VAN BERKEL, Patricius Hendrikus Cornelis, CH
HOWARD, Philip Wilson, GB
|
(73) |
Medimmune Limited,
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
ADC Therapeutics SA, Route de la Corniche 3B, 1066 Epalinges, CH |
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pirolbenzodiazepino-antikūno konjugatai |
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES |
Mokėjimo data | Galiojimo metai | Suma | |
2024-09-19 | 12 | 289.00 EUR |
2025-10-11 |